Up-regulated VCAN promotes motility and invasion of ovarian cancer cells by activating the NF-κB signaling pathway and up-regulating the expression of CD44, matrix metalloproteinase 9, and hyaluronan-mediated motility receptors (Yeung et al., 2013). Here, CD44 is linked to ovarian cancer.